1. Home
  2. PRAX vs SCSC Comparison

PRAX vs SCSC Comparison

Compare PRAX & SCSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRAX
  • SCSC
  • Stock Information
  • Founded
  • PRAX 2015
  • SCSC 1992
  • Country
  • PRAX United States
  • SCSC United States
  • Employees
  • PRAX N/A
  • SCSC N/A
  • Industry
  • PRAX Biotechnology: Pharmaceutical Preparations
  • SCSC Retail: Computer Software & Peripheral Equipment
  • Sector
  • PRAX Health Care
  • SCSC Technology
  • Exchange
  • PRAX Nasdaq
  • SCSC Nasdaq
  • Market Cap
  • PRAX 1.2B
  • SCSC 1.1B
  • IPO Year
  • PRAX 2020
  • SCSC 1994
  • Fundamental
  • Price
  • PRAX $71.76
  • SCSC $48.99
  • Analyst Decision
  • PRAX Strong Buy
  • SCSC Hold
  • Analyst Count
  • PRAX 9
  • SCSC 2
  • Target Price
  • PRAX $146.33
  • SCSC $36.00
  • AVG Volume (30 Days)
  • PRAX 317.5K
  • SCSC 190.8K
  • Earning Date
  • PRAX 11-06-2024
  • SCSC 11-07-2024
  • Dividend Yield
  • PRAX N/A
  • SCSC N/A
  • EPS Growth
  • PRAX N/A
  • SCSC N/A
  • EPS
  • PRAX N/A
  • SCSC 3.14
  • Revenue
  • PRAX $1,605,000.00
  • SCSC $3,159,084,000.00
  • Revenue This Year
  • PRAX N/A
  • SCSC $1.97
  • Revenue Next Year
  • PRAX N/A
  • SCSC $5.08
  • P/E Ratio
  • PRAX N/A
  • SCSC $15.56
  • Revenue Growth
  • PRAX N/A
  • SCSC N/A
  • 52 Week Low
  • PRAX $14.25
  • SCSC $31.01
  • 52 Week High
  • PRAX $86.93
  • SCSC $53.76
  • Technical
  • Relative Strength Index (RSI)
  • PRAX 48.78
  • SCSC 55.77
  • Support Level
  • PRAX $58.84
  • SCSC $48.83
  • Resistance Level
  • PRAX $86.93
  • SCSC $53.76
  • Average True Range (ATR)
  • PRAX 6.09
  • SCSC 1.87
  • MACD
  • PRAX -0.15
  • SCSC 0.40
  • Stochastic Oscillator
  • PRAX 46.00
  • SCSC 61.84

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.

About SCSC ScanSource Inc.

ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Modern Communications and Cloud. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: